Form 4: Procter & Gamble Executive Jennifer L. Davis Reports Stock Sale and RSU Acquisition

Jennifer L. Davis, CEO Health Care at Procter & Gamble, reported the sale of 1,000 shares of common stock and the acquisition of restricted stock units (RSUs).

Summary

• On April 29, 2025, Jennifer L. Davis, CEO Health Care at Procter & Gamble, sold 1,000 shares of P&G common stock at a weighted average price of $161.384.
• The price range for the sale was between $161.38 and $161.40.
• Following the transaction, Davis directly owns 51,964.9178 shares of P&G common stock.
• Davis also indirectly owns 14,838.4112 shares through a retirement plan trustee.
• Additionally, Davis acquired 22.1597 restricted stock units (RSUs) on February 18, 2025, which will be delivered in shares upon retirement, unless deferred.
• The total direct holdings include dividend equivalents in the form of RSUs settled in common stock.
• The reported transactions were filed on April 30, 2025.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive, indicating a neutral sentiment.

Future Outlook

The RSUs will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of Procter & Gamble's executives. It allows investors to monitor management's perspective on the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies like Procter & Gamble, similar to filings made by executives at comparable companies such as Unilever, Nestle, and Johnson & Johnson.
• The reporting requirements are governed by Section 16(a) of the Securities Exchange Act of 1934, ensuring consistent disclosure across the industry.

Stakeholder Impact

• The stock sale and RSU acquisition may have a minor impact on shareholders, providing insight into executive compensation and stock ownership.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Procter & Gamble, PG, Jennifer L. Davis, Stock Sale, Restricted Stock Units, RSU, Form 4, Insider Trading, Beneficial Ownership, Executive Compensation